User login
2017 Hidradenitis Suppurativa4-Part Video Roundtable
Hidradenitis suppurativa (HS) is a chronic inflammatory condition that has a significant impact on the patient's quality of life. In this 4-part video series, viewers will learn about diagnosis issues, acute management, patient perspectives, and clinical pearls. Participants include:
Disclosure: The faculty received modest honoraria from Frontline Medical Communications for their time participating in this roundtable, and maintained complete editorial control over all content presented.
This video roundtable was produced by the Custom Programs division of Frontline Medical Communications.
The editorial staff of Dermatology News and The Journal of Family Practice were not involved in developing the video roundtable.
Dr. Micheletti, Dr. Levitt, and Dr. Lowes have nothing to disclose.
The panelists review common diagnostic pitfalls for HS, including a lack of provider awareness and understanding of the disease. Patients often visit their primary care physician or the emergency room several times before a diagnosis is made. The participants also discuss how to reach a diagnosis when a patient may be hesitant to volunteer information about their condition because of a feeling of shame.
Advertisement
The second video covers management pitfalls of HS, including the overuse of incision and drainage, as well as short-course antibiotics that do not have good efficacy for HS. The panel also discusses the need for improvement in health care utilization patterns.
Advertisement
Learn more about how HS impacts patients, including quality of life issues such as pain, odor, and messiness. Patients with HS are often unable to shave or use deodorant, and face challenges with intimacy and sexual health. The panel also discusses anxiety, depression, and other comorbidities in patients with HS.
Advertisement
In the final video, the panel discusses nonbiologic medical therapies, adjunctive therapy, and when to use biologic therapy. The participants also address how to escalate therapies, as well as what to do when a patient starts to improve.